Clinical Trials on Recurrent Bladder Cancer
Total 56930 results
-
UNC Lineberger Comprehensive Cancer CenterCompletedInvasive Bladder CancerUnited States
-
Anchiano Therapeutics Israel Ltd.CompletedSuperficial Bladder CancerIsrael, United States
-
North Florida/South Georgia Veterans Health SystemAxcan Pharma; North Florida Foundation for Research and EducationCompletedSuperficial Bladder CancerUnited States
-
Eli Lilly and CompanyCompleted
-
Applied Spectral Imaging Ltd.CompletedBladder CancersUnited States
-
William Chu, MD, MSc, FRCPCPhilips Medical SystemsCompletedRecurrent Rectal CancerCanada
-
Haider MahdiMirati Therapeutics Inc.WithdrawnSolid Tumors | Recurrent Endometrial CancerUnited States
-
Asan Medical CenterBoryung Pharmaceutical Co., LtdUnknownAdvanced or Recurrent Endometrial CancerKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterCedars-Sinai Medical CenterCompletedLocally Recurrent/Metastatic Triple Negative Breast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Head and Neck Carcinoma | Recurrent Skin Carcinoma | Recurrent Salivary Gland Carcinoma | Skin Squamous Cell CarcinomaUnited States
-
University Hospital Inselspital, BerneUniversity of Bern; Debiopharm International SA; Werner und Hedy Berger-Janser...RecruitingRecurrent Prostate CancerSwitzerland
-
University of South AlabamaExelixisTerminatedCervical Cancer | Metastatic Cervical Cancer | Recurrent Cervical Cancer | Persistent Cervical CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8United States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
TopLab Company for ART Laboratories Consultation...CompletedRecurrent Implantation Failure (RIF)
-
Turku University HospitalNordic Urothelial Cancer GroupRecruitingBladder Cancer | Invasive Bladder CancerFinland
-
Turku University HospitalNordic Urothelial Cancer GroupRecruitingBladder Cancer | Invasive Bladder CancerFinland
-
Spanish Oncology Genito-Urinary GroupAstraZeneca; MFARActive, not recruiting
-
Eli Lilly and CompanyCompleted
-
Jiangsu Yahong Meditech Co., Ltd aka AsierisRecruitingMuscle Invasive Bladder CancerUnited States, China
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...WithdrawnMuscle-invasive Bladder CancerItaly
-
Tianjin Medical University Second HospitalCSPC Pharmaceutical Group LimitedUnknownMuscle Invasive Bladder CancerChina
-
Catharina Ziekenhuis EindhovenRecruitingRecurrent Rectal CancerNetherlands, Sweden, Belgium, Norway, Portugal
-
National Cancer Center Hospital EastJapan Agency for Medical Research and Development; Japan Clinical Oncology...Recruiting
-
Fudan UniversityUnknownRecurrent Colorectal CancerChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownRecurrent Uterine Corpus Carcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7
-
University Hospital HeidelbergCompletedRecurrent Rectal CancerGermany
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
National Institutes of Health Clinical Center (CC)CompletedLiver Metastases | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerUnited States
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Shanghai JMT-Bio Inc.Not yet recruitingFirst-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
-
Fudan UniversityRecruitingRecurrent Rectal CancerChina
-
Washington University School of MedicineRecruitingRecurrent Rectal CancerUnited States
-
Leiden University Medical CenterErasmus Medical Center; Catharina Ziekenhuis Eindhoven; Amsterdam UMC, location... and other collaboratorsRecruitingRectal Cancer | Recurrent Rectal CancerNetherlands
-
Groupe Oncologie Radiotherapie Tete et CouGustave Roussy, Cancer Campus, Grand ParisCompletedMetastatic or Recurrent Head and Neck Squamous Cell CancerFrance
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
OHSU Knight Cancer InstituteThe Wayne D. Kuni and Joan E. Kuni FoundationCompletedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
National Taiwan University HospitalCompletedLocally Advanced and Recurrent/Metastatic Gastric Cancer
-
NKGen Biotech, Inc.Active, not recruitingMetastatic Cancer | Advanced Solid Tumor | Advanced Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer | Unresectable CarcinomaUnited States
-
ShangHai Ji Ai Genetics & IVF InstituteRecruitingAcupuncture | Recurrent Implantation FailureChina
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingStage IV Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Stage IVB Bladder Cancer AJCC v8 | Bladder Urothelial CarcinomaUnited States
-
University Hospital TuebingenUnknown
-
Zhujiang HospitalRecruiting
-
Jørgen Bjerggaard JensenOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Herlev Hospital and other collaboratorsRecruitingBladder Cancer | Bladder Cancer, MetastaticDenmark
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer... and other collaboratorsCompletedSuperficial Bladder CancerUnited States, Australia, New Zealand, Canada, United Kingdom
-
Brown UniversityLifespanTerminatedBladder Cancer | Invasive Bladder CancerUnited States
-
NYU Langone HealthWithdrawn
-
University of Rome Tor VergataCompletedSuperficial Bladder CancerItaly